Connect with Us
Connect with Us
Working in a lab

Securing a healthier future by preventing viral infections

At Gamma Vaccines we aim to develop innovative vaccines to prevent viral infections, ensuring a healthier future for all

MISSION

Innovative global health solutions

Gamma Vaccines is an early stage company developing innovative technology to produce broad spectrum vaccines against a variety of human and animal viruses, aimed at reducing the incidence of viral diseases and pandemic outbreaks.

About Us
Innovative Vaccines
Scientific Excellence
Global Collaboration

Technology

A new era in
vaccine development

Our vaccines are based on proprietary technologies initially developed in conjunction with leading Australian universities and offer new ways to induce broad spectrum immune responses against important viral pathogens.

Our Technology

Events

Upcoming conferences

News

Latest updates

  • 05/10/2024

    Gamma Vaccines acquires IP to develop NDV vaccine

    Gamma Vaccines has signed a deed of assignment with the University of Adelaide for the rights to commercialise vaccines for NDV (Newcastle disease), either alone or in combination with our other proprietary vaccines.

  • 12/09/2024

    Gamma vaccines signs international collaboration agreement.

    Gamma vaccines has entered a collaboration agreement with Capricorn Technologies GmBH (Austria) and Aptum Adjuvants Ltd (UK) to investigate and develop vaccines that marry Gamma Vaccines manufacturing technology with Capricorn’s novel vaccines and Aptum’s innovative approach to increasing vaccine effectiveness.

View All News